"Is peptide therapy FDA approved?" is one of the most common questions patients ask when first researching this treatment category. The honest answer is more nuanced than a simple yes or no: some peptides are fully FDA-approved pharmaceutical drugs, while others are legally available through FDA-regulated compounding pharmacies under a physician's prescription. Understanding the distinction is essential before starting any peptide protocol.
Key Takeaways
- Multiple peptides are FDA-approved as prescription drugs, including semaglutide (Wegovy, Ozempic) and tesamorelin (Egrifta).
- Other peptides — like BPC-157 and CJC-1295 — are not FDA-approved but can be legally prescribed by a physician and compounded by licensed 503A pharmacies.
- The FDA's compounding framework allows customized medications under strict regulatory oversight, distinct from the commercial approval pathway.
- "Research chemicals" sold without a prescription are not legally intended for human use and fall outside legitimate medical practice.
FDA-Approved Peptide Drugs
Several peptides have completed the FDA's full drug approval process — including Phase I, II, and III clinical trials — and are marketed as branded pharmaceutical drugs. These include:
- Semaglutide — approved as Ozempic (type 2 diabetes), Wegovy (chronic weight management), and Rybelsus (oral diabetes formulation).
- Tirzepatide — approved as Mounjaro (diabetes) and Zepbound (weight management).
- Liraglutide — approved as Victoza (diabetes) and Saxenda (weight management).
- Tesamorelin — approved as Egrifta for HIV-associated lipodystrophy.
- Bremelanotide (PT-141) — approved as Vyleesi for hypoactive sexual desire disorder.
- Sermorelin — historically FDA-approved for pediatric growth hormone deficiency; commercial approval later withdrawn (not for safety reasons).
These peptides have been studied in large randomized controlled trials, have well-characterized safety profiles, and are available as branded products through retail pharmacies with a prescription.
Compounded Peptides Under FDA Oversight
A separate category of peptides is not FDA-approved as commercial drugs but is legally available through compounded prescriptions. The FDA regulates this space under two frameworks:
- 503A compounding pharmacies: Licensed pharmacies that prepare customized medications for individual patients with a valid prescription from a licensed prescriber. Operate under state pharmacy board oversight and FDA Section 503A.
- 503B outsourcing facilities: Larger facilities that produce compounded medications at scale for healthcare providers under stricter FDA oversight, equivalent to cGMP manufacturing standards.
Peptides commonly available through compounding include BPC-157, TB-500, CJC-1295, ipamorelin, selank, semax, and thymosin alpha-1. These are prescribed off-label based on published research evidence and individualized clinical judgment.
The Gray Zone: Research Chemicals
Outside of FDA-approved drugs and compounded prescriptions, some websites sell peptides labeled "for research use only — not for human consumption." These products are not intended for medical use, are not regulated for purity or sterility, and their use as medical treatments carries significant safety risks. Legitimate telehealth practices do not source from these channels.
How to Verify a Peptide's FDA Status
- Check the FDA's Drugs@FDA database at fda.gov for approved drug entries.
- Confirm your prescribing physician is licensed in your state.
- Confirm the compounding pharmacy is state-licensed and operates under 503A or 503B registration.
- Request the pharmacy's accreditation credentials — many are PCAB-accredited, an additional quality mark.
FAQs About Peptide FDA Status
Is compounded semaglutide legal?
Compounded semaglutide has been legally prescribed by physicians when the FDA-listed drug is in shortage. In 2024-2025, the FDA updated its shortage list, affecting compounding eligibility for some semaglutide formulations. Your prescribing physician and pharmacy must comply with current FDA guidance, which evolves.
Can I get BPC-157 with a prescription?
Yes — BPC-157 is not FDA-approved as a commercial drug, but it can be prescribed by a licensed physician and compounded by a licensed 503A pharmacy for an individual patient. The physician must have a clear clinical rationale and follow all applicable state and federal regulations.
Are peptides safe if they're not FDA-approved?
FDA approval is a regulatory designation, not a universal safety verdict. Many compounded peptides have decades of published research behind them. That said, FDA-approved peptides have completed the most rigorous testing. Your physician weighs the evidence, your individual risk factors, and available alternatives when recommending any therapy.
Not sure if peptide therapy is right for you?
Take our free 5-minute assessment. A licensed physician reviews every submission.
Start Assessment →